Home › Funds › Atlas Venture Life Science Advisors, LLC › SION
Atlas Venture Life Science Advisors, LLC position in SION
SIONNA THERAPEUTICS INC · Health Care
Atlas Venture Life Science Advisors, LLC reported holding 2,995,602 shares of SION (SIONNA THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$15.8M, representing 2.50% of its reported portfolio and ranking #7 among its reported holdings. Atlas Venture Life Science Advisors, LLC has disclosed SION holdings in 7 of the last 7 reported quarters, going back to Q1 2025.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Atlas Venture Life Science Advisors, LLC's SION position evolved
Atlas Venture Life Science Advisors, LLC first disclosed a stake in SION in Q1 2025 at 3,694,020 shares (US$38.6M). The position peaked in Q2 2026 at 2,995,602 shares, worth US$131.8M. Across 7 filings, Atlas Venture Life Science Advisors, LLC increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 2,995,602 shares valued at US$15.8M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2025 | 3.69M | $38.64M | New |
| Q2 2025 | 3.69M | $64.09M | Hold |
| Q3 2025 | 3.62M | $106.33M | Reduce |
| Q4 2025 | 3.00M | $123.24M | Reduce |
| Q1 2026 | 3.00M | $120.09M | Hold |
| Q2 2026 | 3.00M | $131.78M | Hold |
| Q3 2026 | 3.00M | $15.76M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About SION and 13F data
SION (SIONNA THERAPEUTICS INC) is a Health Care company. 60 other funds we track also report a position in SION — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$435.7M), TPG GP A, LLC (US$285.7M), ORBIMED ADVISORS LLC (US$112.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding SION
- RA CAPITAL MANAGEMENT, L.P. 9.91M sh · $435.72M · Q2 2026
- TPG GP A, LLC 6.49M sh · $285.71M · Q2 2026
- ORBIMED ADVISORS LLC 2.56M sh · $112.43M · Q2 2026
- Enavate Sciences GP, LLC 2.48M sh · $109.01M · Q2 2026
- PERCEPTIVE ADVISORS LLC 905.00K sh · $39.81M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 680.92K sh · $29.95M · Q2 2026
- Casdin Capital 400.00K sh · $17.60M · Q2 2026
- Sofinnova Investments, Inc. 144.43K sh · $6.35M · Q2 2026
- GordonMD Global Investments LP 136.00K sh · $5.98M · Q2 2026
- Sio Capital Management, LLC 127.81K sh · $5.62M · Q2 2026
- Artia Global Partners LP 119.74K sh · $5.27M · Q2 2026
- First Turn Management, LLC 110.49K sh · $4.86M · Q2 2026
More on Atlas Venture Life Science Advisors, LLC
FAQ
How long has Atlas Venture Life Science Advisors, LLC held SION?
Atlas Venture Life Science Advisors, LLC has disclosed SION holdings in 7 of the last 7 reported quarters, going back to Q1 2025.
What is Atlas Venture Life Science Advisors, LLC's current position in SION?
As of Q3 2026, Atlas Venture Life Science Advisors, LLC holds 3.00M shares of SION (SIONNA THERAPEUTICS INC), valued at $15.76M, representing 2.50% of its reported portfolio and ranking #7.
Has Atlas Venture Life Science Advisors, LLC been buying or selling SION?
In the latest 13F filing (Q3 2026), Atlas Venture Life Science Advisors, LLC held unchanged its position in SION. The position peaked in Q2 2026 at 3.00M shares.
Which other funds hold SION?
Other major institutional holders of SION include RA CAPITAL MANAGEMENT, L.P., TPG GP A, LLC, ORBIMED ADVISORS LLC, among 60 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.